A series of a new type of Schiff bases 1-7, derived from 2-phenyl-3-amino-4(1H)-quinolinone and R-salicyladehyde derivatives wherein R = 3-hydroxy (1), 3,4-dihydroxy (2), 3-methoxy (3), 3-carboxy (4), 3-allyl (5), 5-chloro (6), and 5-nitro (7), was synthesized and structurally characterized. Each of the molecules 1, 3 and 7 consists of three planar moieties (i.e., a quinolinone and two phenyl rings), which are mutually oriented differently depending on the appropriate substituent R and the extent of non-covalent contacts stabilizing the crystal structures. The compounds were studied for their fluorescence properties, where compound 6 yielded the strongest intensity both in the solid phase and in 100 μM ethanol solution with a quantum yield of φ = 3.6% as compared to quinine sulfate used as a standard. The in vitro cytotoxicity of these compounds was tested against the human osteosarcoma (HOS) and breast adenocarcinoma (MCF7) cell lines, revealing no activity up to the concentration of 50 µM.

Regional Centre of Advanced Technologies and Materials Department of Inorganic Chemistry Faculty of Science Palacký University 17 listopadu 12 CZ 77146 Olomouc Czech Republic

Zobrazit více v PubMed

Staskun B. 2-Phenyl-3-(1-methyl-2-indolyl)-4(1H)-quinolone. J. Org. Chem. 1966;31:2674–2676. doi: 10.1021/jo01346a505. PubMed DOI

Hradil P., Grepl M., Hlaváč J., Soural M., Maloň M., Bertolasi V. some new routes for the preparation of 3-amino-2-phenyl-4(1h)-quinolinones from anthranilamides. J. Org. Chem. 2006;71:819–822. doi: 10.1021/jo051303k. PubMed DOI

Agati G., Azzarello E., Pollastri S., Tattini M. Flavonoids as antioxidants in plants: Location and functional significance. Plant Sci. 2012;196:67–76. doi: 10.1016/j.plantsci.2012.07.014. PubMed DOI

Lafuente A.G., Guillamón E., Villares A., Rostagno M.A., Martínez J.A. Flavonoids as anti-infammatory agents: Implications in cancer and cardiovascular disease. Inflamm. Res. 2009;58:537–552. doi: 10.1007/s00011-009-0037-3. PubMed DOI

Sui Z., Jason A., Nguyen V.N., Fernandez J., Bernstein J.I., Hilliard J.J., Barrett J.F., Podlogar B.L., Ohemeng K.A. Synthesis and inhibitory activity of novel Tri- and Tetracyclic quinolines against topoisomerases. Bioorg. Med. Chem. 1998;6:735–742. doi: 10.1016/S0968-0896(98)00030-3. PubMed DOI

Sui Z.H., Nguyen V.N., Altom J., Fernandez J., Hilliard J.J., Bernstein J.I., Barrett J.F., Ohemeng K.A. Synthesis and topoisomerase inhibitory activities of novel aza-analogues of flavones. Eur. J. Med. Chem. 1999;34:381–387. doi: 10.1016/S0223-5234(99)80087-7. DOI

Iwanowicz J.E., Watterson S.H., Murali T.G., Pitts W.J., Gu H.H. Heterocycles that are inhibitors of IMPDH enzyme. 2001081340. WO. 2001 Nov 1;

Soural M., Hlaváč J., Funk P., Džubák P., Hajdúch M. 2-Phenylsubstituted-3-Hydroxyquinolin-4(1H)-one-Carboxamides: Structure-cytotoxic activity relationship study. ACS Comb. Sci. 2011;52:39–44. PubMed

Buchtík R., Trávníček Z., Vančo J., Herchel R., Dvořák Z. Synthesis, characterization, DNA interaction and cleavage, and in vitro cytotoxicity of copper(II) mixed-ligand complexes with 2-phenyl-3-hydroxy-4(1H)-quinolinone. Dalton Trans. 2011;40:9404–9412. doi: 10.1039/c1dt10674k. PubMed DOI

Buchtík R., Trávníček Z., Vančo J. In vitro cytotoxicity, DNA cleavage and SOD-mimic activity of copper(II) mixed-ligand quinolinonato complexes. J. Inorg. Biochem. 2012;116:163–171. doi: 10.1016/j.jinorgbio.2012.07.009. PubMed DOI

Trávníček Z., Vančo J., Hošek J., Buchtík R., Dvořák Z. Cellular responses induced by Cu(II) quinolinonato complexes in human tumor and hepatic cells. Chem. Centr. J. 2012;6:160. doi: 10.1186/1752-153X-6-160. PubMed DOI PMC

Hirano J., Hamase K., Fukuda H., Tomita T., Zaitsu K. Novel stable fluorophore, 6-methoxy-4-quinolone, with strong fluorescence in wide pH range of aqueous media, and its application as a fluorescent labeling reagent. J. Chromatogr. A. 2004;1059:225–231. doi: 10.1016/j.chroma.2004.10.020. PubMed DOI

Yushchenko D.A., Bilokin M.D., Pyvovarenko O.V., Duportail G., Mély Y., Pivovarenko G.V. Synthesis and fluorescence properties of 2-aryl-3-hydroxyquinolones, a new class of dyes displaying dual fluorescence. Tetrahedron Lett. 2006;47:905–908. doi: 10.1016/j.tetlet.2005.11.160. DOI

Bilokin M.D., Shvadchak V.V., Yushchenko D.A., Klymchenko A.S., Duportail G., Mely Y., Pivovarenko G.V. 3-Hydroxybenzo[g]quinolones: Dyes with red-shifted absorption and highly resolved dual emission. Tetrahedron Lett. 2009;50:4714–4719. doi: 10.1016/j.tetlet.2009.06.024. DOI

Issa R.M., Khedr A.M., Rizk H. 1H-NMR, IR and UV/VIS spectroscopic studies of some Schiff bases derived from 2-aminobenzothiazole and 2-amino-3-hydroxypyridine. J. Chin. Chem. Soc. 2008;55:875–884.

Smith B. Infrared Spectral Interpretation. CRC Press; Boca Ranton, FL, USA: 1999.

Biczok L., Berces T., Linschitz H. Quenching processes in hydrogen-bonded pairs: Interactions of excited fluorenone with alcohols and phenols. J. Am. Chem. Soc. 1997;119:11071–11077. doi: 10.1021/ja972071c. DOI

CrysAlis CCD and CrysAlis RED software. Oxford Diffraction Ltd.; Abingdon, Oxfordshire, UK: 2009. Version 1.171.33.52.

Sheldrick G.M. A short history of SHELX. Acta Crystallogr. 2008;A64:112–122. doi: 10.1107/S0108767307043930. PubMed DOI

Brandenburg K., Putz H. Crystal Impact GbR. [(accessed on 26 February 2008)]. Available online: http://www.crystalimpact.com/diamond/references.htm.

Van der Sluis P., Spek A.L. BYPASS: An effective method for the refinement of crystal structures containing disordered solvent regions. Acta Crystallogr. 1990;A46:194–201. doi: 10.1107/S0108767389011189. DOI

Spek A.L. Single-crystal structure validation with the program PLATON. J. Appl. Crystallogr. 2003;36:7–13. doi: 10.1107/S0021889802022112. DOI

Melhuish W.H.J. Quantum efficiencies of fluorescence of organic substances: Effect of solvent and concentration of the fluorescent solute. J. Phys. Chem. 1961;65:229–235. doi: 10.1021/j100820a009. DOI

Vrzal R., Štarha P., Dvořák Z., Trávníček Z. Evaluation of in vitro cytotoxicity and hepatotoxicity of platinum(II) and palladium(II) oxalato complexes with adenine derivatives as carrier ligands. J. Inorg. Biochem. 2010;104:1130–1132. doi: 10.1016/j.jinorgbio.2010.07.002. PubMed DOI